Teknova to report fourth quarter and full year 2023 financial results on march 11, 2024

Hollister, calif., feb. 21, 2024 (globe newswire) -- alpha teknova, inc. (“teknova”) (nasdaq: tkno), a leading producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics, today announced that the company will report its financial results for the fourth quarter and full year ended december 31, 2023, on monday, march 11, 2024, following the close of market.
TKNO Ratings Summary
TKNO Quant Ranking